LFST logo

LFST
LifeStance Health Group Inc

553
Mkt Cap
$2.75B
Volume
2.69M
52W High
$8.09
52W Low
$3.74
PE Ratio
282.00
LFST Fundamentals
Price
$7.05
Prev Close
$6.99
Open
$6.95
50D MA
$6.74
Beta
0.92
Avg. Volume
2.41M
EPS (Annual)
$0.0247
P/B
1.80
Rev/Employee
$129,941.15
$2,979.48
Loading...
Loading...
News
all
press releases
LifeStance Health Group (NASDAQ:LFST) Director Sells $35,758.01 in Stock
LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) Director Robert Bessler sold 5,101 shares of the firm's stock in a transaction on Tuesday, April 21st. The stock was sold at an average...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Insider Selling: LifeStance Health Group (NASDAQ:LFST) Director Sells 5,101 Shares of Stock
LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) Director Robert Bessler sold 5,101 shares of the firm's stock in a transaction on Tuesday, April 21st. The shares were sold at an average...
MarketBeat·3d ago
News Placeholder
LifeStance Health Group, Inc. $LFST Stake Cut by Parcion Private Wealth LLC
Parcion Private Wealth LLC lessened its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 11.0% during the 4th quarter, according to the company in its most recent...
MarketBeat·10d ago
News Placeholder
Tudor Investment Corp ET AL Purchases New Stake in LifeStance Health Group, Inc. $LFST
Tudor Investment Corp ET AL purchased a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 189,038 shares of...
MarketBeat·13d ago
News Placeholder
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Rating of "Moderate Buy" from Brokerages
LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) has been given an average rating of "Moderate Buy" by the nine brokerages that are covering the firm, MarketBeat.com reports. Two...
MarketBeat·14d ago
News Placeholder
JPMorgan Chase & Co. Sells 310,004 Shares of LifeStance Health Group, Inc. $LFST
JPMorgan Chase & Co. lowered its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 56.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·17d ago
News Placeholder
LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale
LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale PR Newswire...
PR Newswire·17d ago
News Placeholder
Tudor Investment Corp ET AL Takes Position in LifeStance Health Group, Inc. $LFST
Tudor Investment Corp ET AL acquired a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 189,038 shares of the company's stock, valued at approx...
MarketBeat·26d ago
News Placeholder
LifeStance Health Group, Inc. (NASDAQ:LFST) Short Interest Update
LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) was the target of a significant drop in short interest in March. As of March 13th, there was short interest totaling 7,805,868 shares, a...
MarketBeat·28d ago
News Placeholder
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) have earned an average rating of "Moderate Buy" from the nine research firms that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, six have given a buy...
MarketBeat·1mo ago
<
1
2
...
>

Latest LFST News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.